VISX' PRK MARKETING FOR STAR EXCIMER LASER EMPHASIZES LARGER PATIENT POPULATION THAN APPROVED FOR SUMMIT DEVICE; VISX GAINS PRK APPROVAL MARCH 27
This article was originally published in The Gray Sheet
Executive Summary
As it kicks off its marketing efforts for the Star excimer laser for photorefractive keratectomy, Visx is claiming that its FDA approval covers a larger patient population than was approved for Summit Technology's SVS Apex device for PRK applications.
You may also be interested in...
Staar Surgical To Offer Ophthalmic Surgeons Stake In Laser-Center Chain
Staar Surgical will allow certain ophthalmic surgeons to purchase an equity stake in its chain of refractive laser eye surgery centers, the firm says.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.